AKT1 and pachyonychia congenita: As depicted in Figure 7A and B, LY294002 effectively mitigated the proliferative effects induced by EMP1. Scratch assays and transwell rescue experiments indicated that inhibiting PI3K/AKT counteracted the EMP1-mediated migration and invasion of PC cells (Fig. 7C–H).